NCT04415073View on ClinicalTrials.gov

A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
CoronavirusCOVIDARDSCytokine StormCytokine Release Syndrome
Interventions
DRUG

SNDX-6352

SNDX-6352

DRUG

Placebo

Placebo comparator

Trial Locations (2)

10467

Montefiore Medical Center, The Bronx

85258

HonorHealth, Scottsdale

Sponsors
All Listed Sponsors
lead

Syndax Pharmaceuticals

INDUSTRY